Selwood Jessica, Dani Melanie, Corbett Richard, Brown Edwina A
Department of Renal Medicine, Hammersmith Hospital, London, UK.
Department of Geriatric Medicine, Hammersmith Hospital, London, UK.
Clin Kidney J. 2025 Jan 22;18(2):sfaf020. doi: 10.1093/ckj/sfaf020. eCollection 2025 Feb.
A multitude of challenges exist when supporting older adults in deciding on the optimal kidney replacement therapy (KRT), including frailty, comorbidity, cognitive impairment, dialysis modality, as well as local availability of services. The combination of these factors can determine treatment outcomes and quality of life (QoL), and as such the care of older people should be tailored to take these into account. Frailty in older people with chronic kidney disease (CKD) leads to higher rates of hospitalization, increased mortality, and a diminished QoL, while cognitive impairment, present in up to 50% of people with CKD, exacerbates these challenges and affects decision making. Dialysis, particularly haemodialysis, can accelerate physical and cognitive decline in frail older adults. Conversely, peritoneal dialysis (PD) presents a home-based alternative that may better support QoL, particularly for people wanting to prioritize treatment flexibility and independence. Assisted PD programmes have emerged as a valuable option for older people who cannot manage home-based care independently, improving access to KRT. Ultimately shared decision making should be employed when discussing KRT, incorporating patient goals, prognostic awareness, and QoL measures. There is also the emerging role of the geriatrician and the need for an integrated Comprehensive Geriatric Assessment. These elements support older adults to make informed choices that align with the individuals' values and health needs. In designing future health services to meet the needs of increasing numbers of older people, there needs to be increased access to assisted PD as well as multidisciplinary working to ensure patient-focused care surrounding KRT in older adults.
在帮助老年人选择最佳肾脏替代疗法(KRT)时存在诸多挑战,包括身体虚弱、合并症、认知障碍、透析方式以及当地服务的可及性。这些因素的综合作用会决定治疗效果和生活质量(QoL),因此对老年人的护理应考虑到这些因素并进行个性化调整。慢性肾脏病(CKD)老年患者的身体虚弱会导致更高的住院率、死亡率增加以及生活质量下降,而高达50%的CKD患者存在认知障碍,这会加剧这些挑战并影响决策。透析,尤其是血液透析,会加速身体虚弱的老年人的身体和认知衰退。相反,腹膜透析(PD)提供了一种居家替代方案,可能更好地支持生活质量,特别是对于那些希望优先考虑治疗灵活性和独立性的人。辅助腹膜透析项目已成为无法独立管理居家护理的老年人的一个有价值的选择,改善了他们获得肾脏替代疗法的机会。最终,在讨论肾脏替代疗法时应采用共同决策,纳入患者目标、预后意识和生活质量指标。老年医学专家的作用也在不断显现,并且需要进行综合的老年综合评估。这些要素有助于老年人做出符合个人价值观和健康需求的明智选择。在设计未来的医疗服务以满足越来越多老年人的需求时,需要增加辅助腹膜透析的可及性,并开展多学科合作,以确保围绕老年患者肾脏替代疗法提供以患者为中心的护理。